These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 29321061)

  • 21. Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis.
    Kuzu M; Kandemir FM; Yildirim S; Kucukler S; Caglayan C; Turk E
    Biomed Pharmacother; 2018 Oct; 106():443-453. PubMed ID: 29990832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crocin protects against cardiotoxicity induced by doxorubicin through TLR-2/NF-κB signal pathway in vivo and vitro.
    Chu X; Zhang Y; Xue Y; Li Z; Shi J; Wang H; Chu L
    Int Immunopharmacol; 2020 Jul; 84():106548. PubMed ID: 32388215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
    Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin ameliorates doxorubicin-induced cardiotoxicity by abrogation of inflammation, apoptosis, oxidative DNA damage, and protein oxidation in rats.
    Benzer F; Kandemir FM; Ozkaraca M; Kucukler S; Caglayan C
    J Biochem Mol Toxicol; 2018 Feb; 32(2):. PubMed ID: 29315967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.
    De Francesco EM; Rocca C; Scavello F; Amelio D; Pasqua T; Rigiracciolo DC; Scarpelli A; Avino S; Cirillo F; Amodio N; Cerra MC; Maggiolini M; Angelone T
    J Cell Physiol; 2017 Jul; 232(7):1640-1649. PubMed ID: 27607345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials.
    Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM
    Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
    Zhang YY; Yi M; Huang YP
    Cell Physiol Biochem; 2017; 43(2):626-635. PubMed ID: 28946137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats.
    Hekmat AS; Navabi Z; Alipanah H; Javanmardi K
    Hum Exp Toxicol; 2021 Oct; 40(10):1781-1795. PubMed ID: 33882726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
    Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
    Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-Coumaric Acid Mitigates Doxorubicin-Induced Nephrotoxicity Through Suppression of Oxidative Stress, Inflammation and Apoptosis.
    Rafiee Z; Moaiedi MZ; Gorji AV; Mansouri E
    Arch Med Res; 2020 Jan; 51(1):32-40. PubMed ID: 32086107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
    He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
    Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trehalose alleviates doxorubicin-induced cardiotoxicity in female Swiss albino mice by suppression of oxidative stress and autophagy.
    Abu-Khudir R; Ibrahim WM; Shams ME; Salama AF
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22859. PubMed ID: 34328254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy.
    Akolkar G; da Silva Dias D; Ayyappan P; Bagchi AK; Jassal DS; Salemi VMC; Irigoyen MC; De Angelis K; Singal PK
    Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H795-H809. PubMed ID: 28710069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity.
    Naderi Y; Khosraviani S; Nasiri S; Hajiaghaei F; Aali E; Jamialahmadi T; Banach M; Sahebkar A
    Biomed Pharmacother; 2023 Feb; 158():114055. PubMed ID: 36495663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.
    Ammar el-SM; Said SA; El-Damarawy SL; Suddek GM
    Pharm Biol; 2013 Mar; 51(3):339-44. PubMed ID: 23134235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved cardioprotective effects of hesperidin solid lipid nanoparticles prepared by supercritical antisolvent technology.
    Saad S; Ahmad I; Kawish SM; Khan UA; Ahmad FJ; Ali A; Jain GK
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110628. PubMed ID: 31753617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Effect of Acetyl-L-Carnitine Against Doxorubicin-induced Cardiotoxicity in Wistar Albino Rats.
    Dundar HA; Kiray M; Kir M; Kolatan E; Bagriyanik A; Altun Z; Aktas S; Ellidokuz H; Yilmaz O; Mutafoglu K; Olgun N
    Arch Med Res; 2016 Oct; 47(7):506-514. PubMed ID: 28262191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
    Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
    Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Olorundare O; Adeneye A; Akinsola A; Kolo P; Agede O; Soyemi S; Mgbehoma A; Okoye I; Albrecht R; Mukhtar H
    Oxid Med Cell Longev; 2020; 2020():1602816. PubMed ID: 33149803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.